PALATIN TECHNOLOGIES, INC. Operating Leases, Rent Expense
PALATIN TECHNOLOGIES, INC. (PTN) reported Operating Leases, Rent Expense of $285.45 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2020-09-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-09-25
- PALATIN TECHNOLOGIES, INC. operating leases, rent expense for fiscal 2019 was $285.45K, a 2.38% decline from fiscal 2018.
- PALATIN TECHNOLOGIES, INC. operating leases, rent expense for fiscal 2018 was $292.41K.
- PALATIN TECHNOLOGIES, INC. operating leases, rent expense for fiscal 2012 was $915.47K, a 26.33% decline from fiscal 2011.
- PALATIN TECHNOLOGIES, INC. operating leases, rent expense for fiscal 2011 was $1.24M, a 18.29% decline from fiscal 2010.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2019-06-30 | $285.45K 10-K · filed 2020-09-25 |
| 2018-06-30 | $292.41K 10-K · filed 2020-09-25 |
| 2012-06-30 | $915.47K 10-K · filed 2012-09-10 |
| 2011-06-30 | $1.24M 10-K · filed 2012-09-10 |
| 2010-06-30 | $1.52M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |